Market Overview:
The global Radiofrequency Ablation System for Interventional Pulmonology market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of lung cancer, technological advancements in radiofrequency ablation systems, and rising demand for minimally invasive procedures. Based on type, the global Radiofrequency Ablation System for Interventional Pulmonology market can be segmented into suitable and not suitable for tumors. The not suitable for tumors segment is expected to account for a larger share of the market than the suitable tumor segment during the forecast period. This can be attributed to factors such as lower accuracy rates and higher complication rates associated with these systems when used on tumors that are located close to vital organs or blood vessels. Based on application, the global Radiofrequency Ablation System for Interventional Pulmonology market can be divided into clinics, hospitals, and others segments.
Product Definition:
A Radiofrequency Ablation System for Interventional Pulmonology is a device used to deliver energy to specific areas of the lungs in order to ablate (or destroy) tissue. This system is used to treat conditions such as lung cancer, pulmonary fibrosis, and other diseases or abnormalities that affect the lungs. The importance of this system lies in its ability to provide a minimally invasive treatment option for patients with various lung conditions.
Suitable for Tumors:
The global Suitable for Tumors, it's usage and growth factor in Radiofrequency Ablation System for Interventional Pulmonology market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Not suitable for tumors:
This equipment uses high-intensity focused ultrasound (HIFU) technology and microwave energy to destroy tissues that obstruct the flow of air in the lungs. This treatment procedure is usually done with a catheter called a radiofrequency ablation catheter, which delivers heat energy to the targeted area of lung tissue.
Application Insights:
Based on application, the global radiofrequency ablation system for interventional pulmonology market is segmented into clinics, hospitals and others. The clinics segment dominated the market in 2017 owing to increasing awareness about RF ablation procedures among general physicians and surgeons. Moreover, this procedure is gaining popularity due to its ease of use and applicability across a variety of applications in different settings.
The hospital segment will expand at the highest CAGR during the forecast period owing to rising demand for minimally invasive treatment options that are associated with fewer complications as compared to conventional methods used for lung ablation such as open surgery or endoscopic techniques. Furthermore, an increase in R&D investments by various companies including Medtronic Plc.,fuzeon Ltd.,and Atreya Corporation has led to development of advanced products suitable for treating various diseases such as cancer which will drive demand over the forecast period.
Regional Analysis:
North America dominated the global radiofrequency ablation system for interventional pulmonology market in 2017. This can be attributed to the presence of well-established healthcare facilities, high adoption rate of advanced technologies, and availability of highly skilled physicians in this region. Moreover, increasing prevalence of lung cancer is also expected to drive regional growth during the forecast period. For instance, according to statistics published by American Cancer Society in 2018; around 160,520 new cases were estimated to be diagnosed in U.S., and 60% deaths were due to Lung Cancer (ICD-9: 671).
Growth Factors:
- Increasing incidence of respiratory diseases: The global incidence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for radiofrequency ablation system for interventional pulmonology market.
- Technological advancements: The technological advancements in radiofrequency ablation system are helping to improve the accuracy and efficiency of the treatment procedures, which is driving the growth of this market.
- Growing awareness about benefits of radiofrequency ablation system: There is growing awareness among physicians and patients about the benefits of using radiofrequency ablation system for treating various respiratory disorders, which is propelling the growth of this market.
- Rising number of training programs on use of RF Ablation System: There has been a rise in number RF Ablation System training programs being conducted by medical device companies, hospitals, and other healthcare institutions across different geographies, which is aiding in wider adoption rateof RF Ablation System products globally .This will further spurthegrowthoftheRFablationsystemmarketinthe coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Radiofrequency Ablation System for Interventional Pulmonology Market Research Report
By Type
Suitable for Tumors, Not suitable for tumors
By Application
Clinics, Hospitals, Others
By Companies
Broncus Medical, Medtronic, Nuvaira Inc, Balmer Medical, Boston Scientific Corporation, Olympus
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Radiofrequency Ablation System for Interventional Pulmonology Market Report Segments:
The global Radiofrequency Ablation System for Interventional Pulmonology market is segmented on the basis of:
Types
Suitable for Tumors, Not suitable for tumors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Broncus Medical
- Medtronic
- Nuvaira Inc
- Balmer Medical
- Boston Scientific Corporation
- Olympus
Highlights of The Radiofrequency Ablation System for Interventional Pulmonology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Suitable for Tumors
- Not suitable for tumors
- By Application:
- Clinics
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radiofrequency Ablation System for Interventional Pulmonology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radiofrequency ablation system is a type of medical device that uses radio waves to destroy tissue. It is used in interventional pulmonology to treat conditions such as chronic obstructive pulmonary disease (COPD), emphysema, and bronchitis.
Some of the major players in the radiofrequency ablation system for interventional pulmonology market are Broncus Medical, Medtronic, Nuvaira Inc, Balmer Medical, Boston Scientific Corporation, Olympus.
The radiofrequency ablation system for interventional pulmonology market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radiofrequency Ablation System for Interventional Pulmonology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radiofrequency Ablation System for Interventional Pulmonology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radiofrequency Ablation System for Interventional Pulmonology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radiofrequency Ablation System for Interventional Pulmonology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radiofrequency Ablation System for Interventional Pulmonology Market Size & Forecast, 2020-2028
4.5.1 Radiofrequency Ablation System for Interventional Pulmonology Market Size and Y-o-Y Growth
4.5.2 Radiofrequency Ablation System for Interventional Pulmonology Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Suitable for Tumors
5.2.2 Not suitable for tumors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radiofrequency Ablation System for Interventional Pulmonology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radiofrequency Ablation System for Interventional Pulmonology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Suitable for Tumors
9.6.2 Not suitable for tumors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Suitable for Tumors
10.6.2 Not suitable for tumors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Suitable for Tumors
11.6.2 Not suitable for tumors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Suitable for Tumors
12.6.2 Not suitable for tumors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Suitable for Tumors
13.6.2 Not suitable for tumors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radiofrequency Ablation System for Interventional Pulmonology Market: Competitive Dashboard
14.2 Global Radiofrequency Ablation System for Interventional Pulmonology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Broncus Medical
14.3.2 Medtronic
14.3.3 Nuvaira Inc
14.3.4 Balmer Medical
14.3.5 Boston Scientific Corporation
14.3.6 Olympus
